Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.
NCT01739946 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2017-08-01
Summary
The goal of this study is to compare protein markers in the urine of patients with and without overactive bladder (OAB) and InterStim®.
Conditions
Sponsors & Collaborators
-
William Beaumont Hospitals
collaborator OTHER -
Michael Chancellor, MD
lead OTHER
Principal Investigators
-
Michael Chancellor, MD · William Beaumont Hospitals
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-12-31
Countries
- United States
Study Locations
More Related Trials
-
Sensory Sensitivity and Urinary Symptoms in the Female Population
NCT01978002 ·Status: COMPLETED
-
The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections
NCT04479709 ·Status: COMPLETED
-
The Women's Urology Center/WISH Database Project
NCT00379002 ·Status: COMPLETED
-
Intravesical Liposomes for Ulcerative Cystitis
NCT01083979 ·Status: COMPLETED ·Phase: NA
-
OAB and the Microbiome
NCT04831801 ·Status: TERMINATED
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC
NCT05223244 ·Status: COMPLETED ·Phase: PHASE4
-
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
NCT02870738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
NCT00714792 ·Status: COMPLETED
-
Bladder Shaper Test
NCT04017000 ·Status: COMPLETED ·Phase: NA
-
Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
NCT05276466 ·Status: UNKNOWN ·Phase: NA
-
Interstitial Cystitis and Urinary pH
NCT03024619 ·Status: COMPLETED
-
Bladder Botox UTI Antibiotic Prophylaxis
NCT06387329 ·Status: RECRUITING ·Phase: PHASE4
-
Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis
NCT01301365 ·Status: UNKNOWN
-
Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
NCT04401176 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis
NCT01138800 ·Status: COMPLETED
-
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
NCT05811377 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Urinary Cytokines in Patients With Overactive Bladder (OAB)
NCT00868621 ·Status: COMPLETED
-
Bladder Environment: Microbiome Oxygen Relationship
NCT02868463 ·Status: COMPLETED
-
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
NCT02868775 ·Status: UNKNOWN
-
Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients
NCT06921746 ·Status: RECRUITING
-
Emotional Urinary Tract Infection
NCT07191041 ·Status: NOT_YET_RECRUITING
-
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
NCT03503513 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Interstitial Cystitis
NCT00056251 ·Status: COMPLETED ·Phase: PHASE2
-
Sensory Processing in Subjects With Painful Bladder Syndrome
NCT00903643 ·Status: COMPLETED